You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,820.8% | -63.0% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -12.2 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 202.9 | 18.2 |
| Price / Book value | -532.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 197.7% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-05-31 | 0.43 | -9.01 | -12.97p | -10.1 | 0.0 | n/a | n/a | 0.0% |
| 2017-05-31 | 0.21 | -5.32 | -9.84p | -14.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-05-31 | 0.24 | -6.34 | -11.41p | -11.1 | 0.0 | n/a | n/a | 0.0% |
| 2019-05-31 | 0.17 | -8.55 | -12.97p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| 2020-05-31 | 0.51 | -9.78 | -13.36p | -8.3 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2021-05-31 | 5.85 | -3.69 | -5.29p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2022-05-31 | 9.05 | -1.15 | -1.77p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Oncimmune enters deal with Augmenta to profile plasma samples Sharecast News | 11 Nov |
|---|---|
| Oncimmune granted funding for Covid-19 research collaboration Sharecast News | 06 Oct |
| Oncimmune enters collaboration with Roche subsidiary Sharecast News | 23 Sep |
| Agreement with Augmenta Bioworks | 11-Nov-20 07:04 |
|---|---|
| Notice of AGM and Posting of Annual Report | 09-Nov-20 07:08 |
| Full year results and progress update | 30-Oct-20 07:07 |
| Replacement: Notice of Full Year Results | 19-Oct-20 08:22 |
| Notice of Full Year Results ended 31 May 2020 | 19-Oct-20 07:06 |